2003
DOI: 10.1016/s0735-1097(03)81786-2
|View full text |Cite
|
Sign up to set email alerts
|

Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

18
255
0
16

Year Published

2006
2006
2022
2022

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 175 publications
(289 citation statements)
references
References 0 publications
18
255
0
16
Order By: Relevance
“…Uric acid may reflect body catabolism and the disturbed catabolic/anabolic balance that frequently occurs in advanced stages of disease, also suggested by higher furosemide use. It remained predictive for all-cause mortality even after adjustment, which fits well previous findings in patients with CHF [14]. The reluctance to use beta-blockers in patients with CHF and COPD is another important finding whose importance can hardly be overestimated.…”
Section: Discussionsupporting
confidence: 87%
“…Uric acid may reflect body catabolism and the disturbed catabolic/anabolic balance that frequently occurs in advanced stages of disease, also suggested by higher furosemide use. It remained predictive for all-cause mortality even after adjustment, which fits well previous findings in patients with CHF [14]. The reluctance to use beta-blockers in patients with CHF and COPD is another important finding whose importance can hardly be overestimated.…”
Section: Discussionsupporting
confidence: 87%
“…Finally, we mention again the relative lack of impact of diuretics (figure 4e, f) on our biomarkers relative to their apparent effect on creatinine (figure 5f). Uric acid has been suggested as a marker of cardiovascular mortality and its level is known to increase in patients with heart failure (Leyva et al, 1998a, b;Anker et al, 2003Sakai et al, 2006, albeit not, it is claimed, when adjusted for diuretic use (Culleton et al, 1999b). It is probably a measure of impaired oxidative capacity (Leyva et al, 1997, b) and it is of interest that it too was observed as being among the most significant biomarkers in our metabolomics data (figure 2, Table 2).…”
Section: Resultsmentioning
confidence: 99%
“…Recent studies suggest that uric acid is biologically active and can stimulate oxidative stress, endothelial dysfunction, inflammation and vasoconstriction. 4 A number of studies showed that UA is an independent risk factor for adverse outcomes of various cardiovascular disease, 5-7 including heart failure, [8][9][10] ischemic stroke, 7,10,11 myocardial infarction, 10, 11 hypertension, 12, 13 and atrial fibrillation. 14 However, the significan of UA in the prognosis of HCM remains to be evaluated.…”
Section: Discussionmentioning
confidence: 99%